The adoption of simple and easy-to-use Web 2.0-inspired technologies and approaches inside the enterprise provides companies with opportunities to improve their collaboration, communication and knowledge sharing.
Outsourcing pharma or biotech research IT can be very difficult to implement but with a well-planned strategy the benefits can easily outweigh the risks.
Service oriented architecture promises to revolutionise the way companies share information internally, as well as with partners, customers and regulators.
IT governance defines a structure of relationships, processes and measures to direct and control IT in order to achieve the enterprise's goals.
By using knowledge tools to better understand a potential new drug’s effectiveness and safety early in the development process, it becomes possible to terminate potentially problematic drugs earlier, saving both time and money.
IT breaches lead to identity theft, counterfeit drugs, low productivity and revenue loss.
The IT spending of companies reflects their strategies to introduce new drugs, enter new markets, and be more competitive in the challenging Asian pharmaceutical market.
Digital Pharma will enable lifesciences organisations to improve operations and decision making across the entire industry value chain.